Ownership history in GEODE CAPITAL MANAGEMENT, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which GEODE CAPITAL MANAGEMENT, LLC reported a position in PROCESSA PHARMACEUTICALS INC (PCSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 15,323 | -287,981 | -94.9% | 0.00% | $44K | $2.88 |
| 2025 Q3 | ADDED | 303,304 | +252,731 | +499.7% | 0.00% | $58K | $4.80 |
| 2025 Q2 | ADDED | 50,573 | +16,160 | +47.0% | 0.00% | $10K | $5.12 |
| 2025 Q1 | ADDED | 34,413 | +12,431 | +56.6% | 0.00% | $13K | $9.25 |
| 2024 Q4 | ADDED | 21,982 | +2,289 | +11.6% | 0.00% | $20K | $22.10 |
| 2024 Q3 | ADDED | 19,693 | +2,456 | +14.2% | 0.00% | $27K | $34.25 |
| 2024 Q2 | INITIATED | 17,237 | — | — | 0.00% | $39K | — |
As of 2025 Q4 — sorted by position size